Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sell in May and go away

<< Previous

Bullboard Posts

Next >>

Comment by Stockfshron Jun 09, 2022 3:50pm

166 Views

Post# 34744981

RE:RE:Sell in May and go away

Hey Bio, The Google search interest appears to simply follow the stock price chart. As such it is not a leading indicator as far as I can see.

I would appreciate your thoughts on a couple of questions I asked awhile back. Is there anything stopping the company from entering a partnership arangement with a company other than Evotec with regards to T1D? Or for Thyroid or Hemophilia A for that matter although early in their development cycle? If not, this could be an announcement at any time that would spur the stock price.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario